Sign up to view this video Join Now Patient Voice, • 9/19/25 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Previous Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Next Leveraging Patient Advocacy To Scale Rare Disease Trials You Might Also Like Leveraging Patient Advocacy To Scale Rare Disease Trials Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials Optimizing Rare Disease Clinical Trials with Real World Data Using NLP & AI Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter What Matters to Payers: Conversations You Should Start During Phase 2
Sign up to view this video Join Now Patient Voice, • 9/19/25 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Previous Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Next Leveraging Patient Advocacy To Scale Rare Disease Trials You Might Also Like Leveraging Patient Advocacy To Scale Rare Disease Trials Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials Optimizing Rare Disease Clinical Trials with Real World Data Using NLP & AI Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter What Matters to Payers: Conversations You Should Start During Phase 2
